For the patients, we must do better.
8th Annual Cell & Gene Therapy Innovation Leaders Summit 2025
10th & 11th September 2025
Hyatt Regency Barcelona Tower, Spain
The 8th Annual #CGTI Leaders Summit 2025: Purpose-Driven Leadership. Scalable Innovation. Shared Accountability.
Cell and Gene Therapy Innovation Leaders Summit is your private invitation to join an in-person-only gathering of the most forward-thinking minds in cell and gene therapy. Designed exclusively for senior leaders, this summit empowers a select group of up to 200 attendees to pause, connect, and rethink the way we lead, innovate, and grow together.
Whether you’re navigating volatile supply chains, scaling manufacturing infrastructure, reimagining your digital roadmap, or seeking capital alignment, this is the one space where science meets strategy, and opportunity meets action.
This summit is where leadership becomes tangible, relationships become assets, and collective ambition is re-aligned around a single truth:
For the patients, we must do better.
PAST SPEAKERS
Paolo Martini
Chief Research & Development Officer at ReAlta Life Sciences former CSO at Moderna
Warner Biddle
CEO at Kyverna Therapeutics former interim CEO at Kite a Gilead Company
Gwendolyn Binder PhD
President, Science and Technology at Cabaletta Bio
LEADERS SHAPING THE FUTURE
ADVISORY
“For the patients, we must do better."
ADVISORY
“Our very survival depends on our ability to stay awake, to adjust to new ideas, to remain vigilant and to face the challenge of change.” – Martin Luther King ...
The era ahead demands bold moves, not business as usual. Let’s align, evolve, and act.
Over two powerful days behind closed doors, the sharpest minds in biotech and pharma will break down silos, trade unfiltered insight, and shape the future of cell and gene therapy - together.
SUMMIT INSIGHTS
200+
Up to 200 decision-makers in person. Previous attendee demographics include 50% EMEA, 30% America and 20% ROW
20%
20% best-of-breed vendors providing solutions to combat the manufacturing, scale-up & R&D hurdles of today's C>
06
Journey of CXO presentations. Six insightful, powerful and inspirational talks from CXOs in the industry
02
Exclusive in-person networking, over 2 days in Barcelona, on the 10th and 11th of September
7+
Pre-scheduled and pre-qualified one-to-one meetings with delegates who influence or make a decision
90%
Over 90% of our attendance provided positive feedback. Please click here to see what our delegation has to say
WHO ATTENDS
-
C-suite executives from biotech and pharma
-
Senior regulatory and health policy leaders
-
Heads of R&D and scientific affairs
-
VPs of manufacturing, operations, and QA
-
Investors and strategic partners in life sciences
-
Automation, digital, and bioprocessing innovators
WHY ATTEND
-
Address trade tariffs and geopolitical pressures
-
Explore scalable manufacturing and automation
-
Align with evolving regulatory frameworks
-
Build strategic, cross-border partnerships
-
Advance patient access and health equity
-
Engage in 1:1 meetings and curated networking
IN PERSON ONLY
-
Chief Technical Officer (CTO)
-
VP of Manufacturing/Operations
-
Chief Scientific Officer (CSO)
-
Head of R&D
-
Chief Business Officer (CBO)
-
VP of Business Development
-
Head Supply Chain/Procurement
-
Automation/Bioprocessing
-
Robotics/Digital Manufacturing
WHY ATTEND
Exploring opportunities for small-scale CDMOs
Insights into key pain points such as shortage of talent and rising costs of supply chain
A deep dive into emerging biopharma pipelines and innovative emerging technologies
New innovations and strategies driving costs down and improving the manufacturing process
The promises and challenges of new therapeutic modalities
Leveraging innovation to bridge the gap from Gene to GMP
Executive training for commercial innovation and how to make a profitable growth
Navigating pricing, market access and reimbursement framework
Regulatory updates and compliance
Why Now?
The pace of biotechnological disruption is exponential, but so is the risk of stagnation. Regulatory uncertainty, capital pressure, AI-driven acceleration, and supply instability are not going away.
You can react to change or lead it.
As the industry scales to meet global demand, leaders face mounting geopolitical pressures, supply chain volatility, and regulatory complexity - all while driving scientific innovation and ensuring patient access.
This summit offers exclusive access to insights, strategies, and connections that can’t be found anywhere else. It’s not just another conference - it’s where executives shape the future of cell and gene therapy.
INDUSTRY SECTOR
-
Cell and gene therapy developers
-
Biotech and large pharmaceutical companies
-
Contract Development & Manufacturing (CDMOs)
-
Regulatory agencies and health authorities
-
AI, automation, and robotics providers
-
Healthcare investment and venture capital firms
WHY SPONSOR?
-
Connect directly with decision-makers
-
Influence the CGT commercial agenda
-
Lead high-Impact sessions or panels
-
Showcase transformative technologies
-
Align with a mission-led, senior audience
-
Strengthen market position in the EU CGT space
SPONSOR BENEFITS
-
Thought leadership via speaking opportunities
-
1:1 meetings with qualified C-level delegates
-
Brand exposure across digital and on-site media
-
Access to senior buyers and licensing teams
-
Exclusive networking dinner with VIP attendees
-
Insight into near-term investment and RFP cycles
SPEAKERS 2025
For the patients, we must do better.
Together, we will.
Innovation doesn’t scale itself. Regulations don’t write themselves. Talent doesn’t stay unless leadership evolves.
This summit is your space to evolve with it - alongside the only peers who understand the stakes.
PREVIOUS SPEAKERS
Innovation imperative: Co-locating CGTI & DDIF 2025
As the life sciences landscape evolves, so must how we lead. Co-locating CGTI & DDIF 2025 brings together discovery, development, and delivery. We can no longer afford to make decisions in isolation. We must break silos, challenge our own perspectives, and collaborate across the full continuum.
If you influence strategy, this is a space to see the bigger picture, and engage with peers shaping the future. It’s not just timely, it’s necessary.
